Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Financial Results

SMS Pharmaceuticals Financial Results

SMS Pharmaceuticals reported audited FY26 results and recommended a ₹0.40 per share final dividend. The company also approved shifting its registered office within Hyderabad.

Key figures
Value₹0.40 Cr
Source

BSE filing, NSE: SMSPHARMA. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

SMS Pharmaceuticals Ltd: key numbers

Share price
₹475.45
Market cap
₹4,215 Cr
Revenue (annual)
₹886.9 Cr
Net profit (annual)
₹102.0 Cr
P/E (TTM)
41.2×Sector 46.1×
Promoter holding
68.07%+0.00% QoQ
FII holding
1.18%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from SMS Pharmaceuticals Ltd

All →

Other financial results announcements

All →